Dr. Öğr. Üyesi ANT UZAY

Yayın Ağı

SCI, SSCI ve AHCI İndekslerine Giren Dergilerde Yayınlanan Makaleler 20

1. BEGEV is an Effective Therapy for Heavily Pretreated and Platinum-Resistant Relapsed/Refractory Hodgkin's Lymphoma Patients: A Single Center Real-Life Experience

UZAY A., Tasci E. S., Gundogdu Y., Mutlu A. U., Yetis T., Kosan B., et al.

INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION , 2024 (SCI-Expanded) Sürdürülebilir Kalkınma

2. Treosulfan is a safe and effective alternative to busulfan for conditioning in adult allogeneic HSCT patients: Data from a single center

UZAY A., Gundogdu Y., Kosan B., Yetis T., Karti S. S.

CANCER MEDICINE , cilt.13, sa.10, 2024 (SCI-Expanded) Sürdürülebilir Kalkınma

3. Outcomes of Treosulfan Vs. Busulfan Based Conditioning Regimens in Adult Patients Undergoing Allogeneic HSCT: Real Life Data from a Single Center

Uzay A., Kartı S. S.

BLOOD , sa.142, ss.6958, 2023 (SCI-Expanded)

4. Glofitamab in relapsed/refractory diffuse large B-cell lymphoma: Real-world data

Atesoglu E. B., Gulbas Z., UZAY A., ÖZCAN M., ÖZKALEMKAŞ F., Dal M. S., et al.

HEMATOLOGICAL ONCOLOGY , cilt.41, ss.663-673, 2023 (SCI-Expanded)

5. Polatuzumab vedotin, rituximab, and bendamustine combination in relapsed or refractory diffuse large B-cell lymphoma: a real-world data from Turkey

Dal M. S., Ulu B. U., UZAY A., Akay O. M., Beşışık S., Yenerel M. N., et al.

Annals of Hematology , cilt.102, sa.1, ss.133-140, 2023 (SCI-Expanded)

6. Daily low dose intravesical cidofovir for the treatment of BK virus associated hemorrhagic cystitis after allogeneic stem cell transplantation.

Uzay A., Gündoğdu Y., Koşan B., Yetiş T., Gür H., Okuturlar Y., et al.

Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy , cilt.29, sa.1, ss.67-71, 2023 (SCI-Expanded) Sürdürülebilir Kalkınma

7. Effects of neuromuscular electrical stimulation combined with resistance exercises on muscle strength in adult hematological cancer patients: A randomized controlled study

Safran E. E., Mutluay F., Uzay A.

LEUKEMIA RESEARCH , cilt.121, 2022 (SCI-Expanded)

8. Brentuximab vedotin consolidation therapy after autologous stem-cell transplantation in patients with high-risk Hodgkin lymphoma: Multicenter retrospective study

Akay O. M., ÖZBALAK M. M., PEHLİVAN M., Yildiz B., UZAY A., Yigenoglu T. N., et al.

HEMATOLOGICAL ONCOLOGY , cilt.39, sa.4, ss.498-505, 2021 (SCI-Expanded)

9. Brentuximab Vedotin Consolidation Therapy after Autologous Stem-Cell Transplantation in Patients with High-Risk Hodgkin Lymphoma: Multi-Center Retrospective Study

Ozbalak M., Akay O. M., PEHLİVAN M., Yildiz B., UZAY A., Yigenoglu T. N., et al.

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA , cilt.21, 2021 (SCI-Expanded)

10. Ruxolitinib for Glucocorticoid-Refractory Chronic Graft-versus-Host Disease.

Zeiser R., Polverelli N., Ram R., Hashmi S. K., Chakraverty R., Middeke J. M., et al.

The New England journal of medicine , cilt.385, ss.228-238, 2021 (SCI-Expanded)

11. Ruxolitinib Vs Best Available Therapy in Patients With Steroid-Refractory/Dependent Chronic GRAFT-VS-HOST Disease (CGVHD): Subgroup Analyses of Overall Response Rate in The Phase 3 Reach3 Trial

Locatelli F., Polverelli N., Ram R., Hashmi S. K., Chakraverty R., Middeke J. M., et al.

BONE MARROW TRANSPLANTATION , cilt.56, ss.74-76, 2021 (SCI-Expanded)

12. Fusariosis manifesting as targetoid purpuric cutaneous lesions in immunocompromised patients.

Erdemoglu Y., AYDINGOZ I. E., Ustun C., Uzay A., Besli Y., Ozturk Durmaz E., et al.

Journal of the European Academy of Dermatology and Venereology : JEADV , cilt.34, sa.11, 2020 (SCI-Expanded)

13. Tedaviye yanıtsız pulmoner kronik graft versus host hastalığında umut vadeden ajan olarak ibrutinib kullanımı

Uzay A.

Biology Of Blood And Marrow Transplantation , cilt.26, sa.3, ss.191-192, 2020 (SCI-Expanded)

14. Rh (D) alloimmunization treated by double filtration plasmapheresis

GÖKÇAY BEK S., EREN N., UZAY A., BAKIRDÖĞEN S.

TRANSFUSION AND APHERESIS SCIENCE , cilt.58, sa.1, ss.83-86, 2019 (SCI-Expanded)

15. Does it take three to tango? An unsuspected multimorbidity of CD8(+) T cell lymphoproliferative disorder, malaria, and EBV infection

Ekemen S., Uzay A., Bassullu N., Dikicioglu-Cetin E., Matsuda K., Ince Ü., et al.

MALARIA JOURNAL , 2018 (SCI-Expanded)

16. Myelodysplastic syndrome with t(9;22)(p24;q11.2), a BCR-JAK2 fusion: case report and review of the literature

Kantarcioglu B., Kaygusuz-Atagunduz I., UZAY A., TOPTAŞ T., Tuglular T. F., Bayik M.

International Journal of Hematology , cilt.102, sa.3, ss.383-387, 2015 (SCI-Expanded)

17. The prognostic value of CD49d expression in Turkish patients with chronic lymphocytic leukemia Türk kronik lenfositik lösemi hastalarında CD49d ekspresyonunun hastalık seyri üzerindeki etkisi

Uzay A., TOPTAŞ T., Kaygusuz I., Demiralp E. E., Tuǧlular T. F., Bayik M.

Turkish Journal of Hematology , cilt.29, sa.4, ss.354-360, 2012 (SCI-Expanded)

18. Bortezomib in patients with renal impairment

Kaygusuz I., Toptas T., Aydin F., Uzay A., Firatli-Tuglular T., Bayik M.

Hematology , cilt.16, sa.4, ss.200-208, 2011 (SCI-Expanded)

19. Bortezomib: A new therapeutic option for POEMS syndrome

Kaygusuz I., Tezcan H., Cetiner M., Kocakaya O., Uzay A., Bayik M.

European Journal of Haematology , cilt.84, sa.2, ss.175-177, 2010 (SCI-Expanded)

20. Human herpes virus 8-unrelated primary effusion lymphoma-like lymphoma: Report of a rare case and review of the literature

Adiguzel C., BOZKURT S., Kaygusuz I., Uzay A., Tecimer T., Bayik M.

APMIS , cilt.117, sa.3, ss.222-229, 2009 (SCI-Expanded)

Diğer Dergilerde Yayınlanan Makaleler 5

1. Comparison of single day versus two-and three- day fractionated infusion of peripheral stem cells in autologous transplantation

UZAY A., RATİP S., OVALI E.

Acıbadem Üniversitesi Sağlık Bilimleri Dergisi , cilt.15, sa.3, ss.212-219, 2024 (Hakemli Dergi)

2. Atypical presentation of medication-related osteonecrosis of the jaw in a young male patient undergoing chemotherapy for acute lymphoblastic leukemia

BAYRAM F., FATTAHZADE S., UZAY A., ÖZKAN Y.

Oral Oncology Reports , cilt.8, ss.100115, 2023 (Scopus)

3. Successful preoperative treatment with plasmapheresis of patients with hyperthyroidism.

Bahşi Ş., Uzay A., Rustemova N., Önder F. O., Çelik Ö.

Turkish Journal of Endocrinology and Metabolism , cilt.22, ss.113-116, 2018 (ESCI)

4. Successful Preoperative Treatment with Plasmapheresis of Patients with Hyperthyroidism

Bahsi S., Uzay A., Rustemova N., Onder F. O., Celik Ö.

TURKISH JOURNAL OF ENDOCRINOLOGY AND METABOLISM , cilt.22, sa.2, ss.113-116, 2018 (Hakemli Dergi) Sürdürülebilir Kalkınma

5. Precursor B-lymphoblastic lymphoma mimicking: An acute subdural hematoma

Uzay A., Ratip S., Elmaci I., Ozdemirli M.

Acta Haematologica Polonica , cilt.47, sa.4, ss.258-262, 2016 (Scopus)

Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 7

1. SERONEGATİF ROMATOİD ARTRİTİ TAKLİT EDEN MULTİPL MYELOM OLGUSU

Dönmezer Ç., Ezici A., Gökmen İ. B., Uzay A., Okuturlar Y.

25. ULUSAL İÇ HASTALIKLARI KONGRESİ, Antalya, Türkiye, 8 - 12 Kasım 2023, ss.523-524, (Özet Bildiri)

2. yüksek riskli Hodgkin lenfoma hastalarında otological kök hücre nakli sonrası konsolidasyon amaçlı brentuksimab vedotin: çok merkezli gerçek hayat verileri

Uzay A.

25th Congress of the European Hematology Association , Frankfurt, Almanya, 11 - 14 Haziran 2020, sa.3573, ss.1-2, (Özet Bildiri)

3. Comparison of outcomes of total body irradiation (TBI) vs non-TBI conditioning regimens in acute lymphoblastic leukemia for allogeneic transplantation

Bekoz H. S., Sevindik O. G., Ozcelik T., Arat M., Hindilerden I. Y., Besisik S. K., et al.

45th Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation (EBMT), Frankfurt, Almanya, 24 - 27 Mart 2019, cilt.54, ss.217-218, (Özet Bildiri)